HOME >> MEDICINE >> NEWS
Many people with MS report financial strain related to health care

A Harvard-based study of insurance coverage involving a nationwide sampling of people with multiple sclerosis found that although they had higher than average rates of insurance coverage, many experienced financial strain related to obtaining adequate health care, including paying for their medications. The study, commissioned by the National MS Society, was conducted by Drs. Lisa Iezzoni and Long Ngo and published in an early online release January 29, 2007 in the journal Multiple Sclerosis (http://msj.sagepub.com/cgi/content/abstract/1352458506071356v1).

Study Details: The study was the largest ever undertaken to explore insurance concerns in people with MS. It was based on 30-minute phone interviews with 983 working-age individuals across the U.S. with multiple sclerosis from among the client mailing list of the National MS Society. Most participants were women (79%), white (86%), married or living with a partner (67%), with at least some college education (72%), and unemployed (60%). Half reported having MS for greater than ten years, and most (73%) reported having relapsing-remitting MS. The authors suggested that, since these demographics mirror in many respects those from other well-designed studies, the results can be generalized to the MS population as a whole.

The interview covered questions about MS history, health insurance, disability and life insurance, as well as financial concerns related to obtaining MS medications and other health services.

Findings: A high percentage (96%) of survey participants reported having at least some health insurance, which is a higher rate of coverage than that of the general population, which for all ages is about 86%. However, there is a high level of dependence on governmental programs; about 40% of participants were covered by public health insurance, primarily Medicare and/or Medicaid, in contrast to only
'"/>

Contact: Arney Rosenblat
arney.rosenblat@nmss.org
212-476-0436
National Multiple Sclerosis Society
30-Jan-2007


Page: 1 2

Related medicine news :

1. Warfarin better than aspirin at stroke prevention in elderly people with atrial fibrillation
2. Preventive treatments in elderly people needs rethinking
3. Why do people have sex?
4. Children and young people show elevated leukaemia rates near nuclear facilities
5. Do people listen to heat warnings?
6. Rising skin cancer rates are more likely to affect wealthy people, says 12-year review
7. Avian influenza on peoples minds
8. Study shows Diachrome improves blood sugar control in people with type 2 diabetes
9. Antipsychotic drugs increase risk of death in older people with dementia
10. Antipsychotic drugs increase risk of death in older people with dementia
11. Transformation for people with AIDS on the horizon

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Many people with report financial strain related health care

(Date:3/6/2015)... Protein identification is increasingly being ... science research including drug discovery, diagnostics, immunology and ... was valued at $1,569.00 million in 2014 and ... 10.63% to reach $2,600.28 million in 2019. , ... protein based on protein size, shape, sequence and ...
(Date:3/6/2015)... As healthcare providers create one ... from disparate systems, they are using OnBase by ... efficiency. Enterprise content management (ECM) solutions ... IT solutions, including electronic medical records (EMR), enterprise ... , The following organizations have recently integrated ...
(Date:3/6/2015)... March 06, 2015 Saving Moses, a ... the world is traveling to Angola, Africa March 7-14 ... their malnutrition program. , This will be the organizations ... Angola, demonstrating their commitment to the region’s population by ... team will engage with the mothers and babies of ...
(Date:3/6/2015)... 06, 2015 Follow us on ... pharmacokinetics of a drug refers to testing of absorption, ... an organism. When toxicity studies are clubbed together with ... ADME/Tox. Increasing focus on lowering costs and time during ... worldwide. The traditional drug development model uses toxicity and ...
(Date:3/6/2015)... March 06, 2015 “On Tap” takes the ... the grand stage, to the silver screen and to modern ... precision toe-tapping numbers and their famous eye-high kicks! Producers, directors ... rich history of tap dancing in this robust show, showcasing ... of the United States. , “On Tap” is proud ...
Breaking Medicine News(10 mins):Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 2Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 3Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2
(Date:3/6/2015)... , March 6, 2015  Palatin Technologies, Inc. (NYSE MKT: ... 27 th Annual ROTH Conference on Wednesday, March 11, ... held at the Ritz Carlton Laguna Niguel in ... Spana , Ph.D., President and Chief Executive Officer of Palatin ... programs. About Palatin Technologies, Inc. ...
(Date:3/6/2015)... , March 6, 2015   Hospira, Inc. ... Food and Drug Administration (FDA) on today,s FDA approval of ... . This is a watershed moment for improving patient access ... leading global provider of biosimilars, Hospira has seen first-hand the ... a proud participant in these early stages of the development ...
(Date:3/6/2015)... March 6, 2015  Aethlon Medical, Inc. (OTCQB:AEMD), the ... diseases and cancer, today announced that James A. ... present a corporate overview at the 27th Annual ROTH ... time.  Aethlon was previously scheduled to present at 5:30 ... will be held at The Ritz-Carlton Hotel in ...
Breaking Medicine Technology:Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2
Cached News: